Both peptides have been approved by the FDA as safe and effective for specific indications, although sermorelins approval was previously withdrawn for commercial reasons
For everyone else, the practical answer is now telehealth cash-pay which is fully legal in Pennsylvania under the PA Department of States telemedicine guidance and Act 42 of 2024, and which is how PlexusDx Weight Management Protocols deliver to all 50 states including PA, with no membership fee and no insurance dependency
In June 2025, Eli Lilly reported Phase III ACHIEVE-1 Survodutide (BI 456906): Boehringer Ingelhium Survodutide (BI 456906) is a GCGR/GLP1 dual agonist being developed by Boehringer Ingelhium
Center SA, Harte J, Watrous D, Reynolds A, Watson TD, Markwell PJ: The clinical and metabolic effects of rapid weight loss in obese pet cats and the influence of supplemental oral L-carnitine
y l sn phm bn chy ti Hn Quc thi gian qua, v ang rt HOT trn th trng
The paper reported that most cardiometabolic variables moved toward baseline after withdrawal, not that every variable became identical to baseline